Neurogene Inc. Accounts and Other Receivables, Net, Current
Neurogene Inc. (NGNE) had Accounts and Other Receivables, Net, Current of $32.00 thousand as of 2015-12-31, per its 10-K filed 2016-03-14.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AccountsAndOtherReceivablesNetCurrent · last filed 2016-03-14
- 2015-12-31: Accounts and Other Receivables, Net, Current $32.00K.
- 2015-09-30: Accounts and Other Receivables, Net, Current $19.00K.
- 2015-06-30: Accounts and Other Receivables, Net, Current $72.00K.
- 2015-03-31: Accounts and Other Receivables, Net, Current $57.00K.
| Period end | Accounts and Other Receivables, Net, Current | Accounts and Other Receivables, Net, Current as first filed |
|---|---|---|
| 2015-12-31 | $32.00K 10-K · filed 2016-03-14 | |
| 2015-09-30 | $19.00K 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $72.00K 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $57.00K 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $65.00K 10-K · filed 2016-03-14 | $65.45K 10-K · filed 2015-03-16 |
| 2014-09-30 | $76.24K 10-Q · filed 2014-11-04 | |
| 2014-06-30 | $33.38K 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $66.53K 10-Q · filed 2014-05-13 | |
| 2013-12-31 | $27.95K 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |